Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of the investigational drug L608 in healthy adults; the trial lists Pulmonary arterial hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• L608

Snippet

Sponsor: Pharmosa Biopharm Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: RECRUITING